Zongren Wang, Bin Huang, Cheng Luo, Yukun Wu, Jiahao Lei, Junxing Chen. "PUNCH03: Preliminary results from a phase II study of disitamab vedotin combined with tislelizumab and Bacillus Calmette-Guerin (BCG) in Her2-positive high-risk non-muscle-invasive bladder cancer (HR NMIBC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4597